Oral candidosis – Clinical challenges of a biofilm disease

References

• Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axell T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. (2007). Oral lichen planus and oral lichenoid lesions, diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103 Suppl, S25 e21-12.
   Google Scholar
• Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, Lopez-Ribot JL. (2003). Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother, 47, 3657–3659.
   PubMed Web of Science ®Google Scholar
• Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, Lopez-Ribot JL. (2002). In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother, 46, 3591–3596.
   PubMed Web of Science ®Google Scholar
• Bagg J, Jackson MS, Petrina Sweeney M, Ramage G, Davies AN. (2006). Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer. Oral Oncol, 42, 487–492.
   Google Scholar
• Bensadoun RJ, Daoud J, El Gueddari B, Bastit L, Gourmet R, Rosikon A, Allavena C, Ceruse P, Calais G, Attali P. (2008). Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis, a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer, 112, 204–211.
   PubMed Web of Science ®Google Scholar
• Calderone RA. (2002). Candida and candidiasis. Washington, DC: ASM Press.
   Google Scholar
• Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA. (2001). Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res, 80, 903–908.
   PubMed Web of Science ®Google Scholar
• CLSI. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts– Second Edition, Approved Standard M27-A2. Wayne, PA, USA, National Committee for Clinical Laboratory Standards.
   Google Scholar
• Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G. (2008). Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol, 23, 377–383.
   PubMedGoogle Scholar
• Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. (1995). Microbial biofilms. Annu Rev Microbiol, 49, 711–745.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. (1999). Bacterial biofilms, a common cause of persistent infections. Science, 284, 1318–1322.
   PubMed Web of Science ®Google Scholar
• Coulthwaite L, Verran J. (2007). Potential pathogenic aspects of denture plaque. Br J Biomed Sci, 64, 180–189.
   PubMed Web of Science ®Google Scholar
• Davis SL, Vazquez JA, McKinnon PS. (2007). Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother, 41, 568–573.
   PubMed Web of Science ®Google Scholar
• Domingues-Ferreira M, Grumach AS, Duarte AJ, De Moraes-Vasconcelos D. (2009). Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Med Mycol, 47, 201–205.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. (2002). Biofilms, survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 15, 167–193.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Samaranayake LP. (2001). Adjunctive use of chlorhexidine in oral candidoses, a review. Oral Dis, 7, 11–17.
   PubMed Web of Science ®Google Scholar
• EUCAST. (2008). EUCAST definitive document EDef 7.1, method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect, 14, 398–405.
   PubMedGoogle Scholar
• Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. (2006). Time to initiation of fluconazole therapy impacts mortality in patients with candidemia, a multi-institutional study. Clin Infect Dis, 43, 25–31.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. (2010). Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog, 6, e1000713.
   PubMed Web of Science ®Google Scholar
• Grimoud AM, Lodter JP, Marty N, Andrieu S, Bocquet H, Linas MD, Rumeau M, Cazard JC. (2005). Improved oral hygiene and Candida species colonization level in geriatric patients. Oral Dis, 11, 163–169.
   PubMed Web of Science ®Google Scholar
• Hammer KA, Carson CF, Riley TV. (2004). Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother, 53, 1081–1085.
   PubMed Web of Science ®Google Scholar
• Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Korpela R. (2007). Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. J Dent Res, 86, 125–130.
   PubMed Web of Science ®Google Scholar
• He XY, Meurman JH, Kari K, Rautemaa R, Samaranayake LP. (2006). In vitro adhesion of Candida species to denture base materials. Mycoses, 49, 80–84.
   Google Scholar
• Jarvensivu A, Hietanen J, Rautemaa R, Sorsa T, Richardson M. (2004). Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo. Oral Dis, 10, 106–112.
   PubMed Web of Science ®Google Scholar
• Jenkinson HF, Lamont RJ. (2005). Oral microbial communities in sickness and in health. Trends Microbiol, 13, 589–595.
   PubMed Web of Science ®Google Scholar
• Jose A, Coco BJ, Milligan S, Young B, Lappin DF, Bagg J, Murray C, Ramage G. (2010). Reducing the incidence of denture stomatitis, are denture cleansers sufficient? J Prosthodont, 19, 252–257.
   PubMedGoogle Scholar
• Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. (2002). Antifungal susceptibility of Candida biofilms, unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother, 46, 1773–1780.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E. (2009). Significance of the isolation of Candida species from airway samples in critically ill patients, a prospective, autopsy study. Intensive Care Med, 35, 1526–1531.
   PubMed Web of Science ®Google Scholar
• Milgrom P, Ly KA, Rothen M. (2009). Xylitol and its vehicles for public health needs. Adv Dent Res, 21, 44–47.
   PubMedGoogle Scholar
• Morrell M, Fraser VJ, Kollef MH. (2005). Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained, a potential risk factor for hospital mortality. Antimicrob Agents Chemother, 49, 3640–3645.
   PubMed Web of Science ®Google Scholar
• Naglik JR, Challacombe SJ, Hube B. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev, 67, 400–428, table of contents.
   PubMed Web of Science ®Google Scholar
• Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, Tappuni AR, Rodgers CA, Woodman AJ, Challacombe SJ, Schaller M, Hube B. (2008). Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiol, 154, 3266–3280.
   PubMed Web of Science ®Google Scholar
• Odds FC. (2002). Candida and candidosis. London: Baillière Tindall.
   Google Scholar
• Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. (2004). Guidelines for treatment of candidiasis. Clin Infect Dis, 38, 161–189.
   PubMed Web of Science ®Google Scholar
• Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Jr., Mowat E, Ramage G, Lopez-Ribot JL. (2008). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc, 3, 1494–1500.
   PubMed Web of Science ®Google Scholar
• Pizzo G, Giuliana G, Milici ME, Giangreco R. (2000). Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis, and Candida krusei. New Microbiol, 23, 63–71.
   Google Scholar
• Rajendran R, Robertson DP, Hodge PJ, Lappin DF, Ramage G. (2010). Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia, 170, 229–235.
   PubMed Web of Science ®Google Scholar
• Ramage G, Jose A, Coco BJ, Rajendran R, Rautemaa R, Murray C, Lappin DF, Bagg J. (2011). Mouthwashes are more efficient than azole antifungals against Candida albicans biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 111,456–460.
   PubMed Web of Science ®Google Scholar
• Ramage G, Martinez JP, Lopez-Ribot JL. (2006). Candida biofilms on implanted biomaterials, a clinically significant problem. FEMS Yeast Res, 6, 979–986.
   PubMed Web of Science ®Google Scholar
• Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. (2009). Our current understanding of fungal biofilms. Crit Rev Microbiol, 35, 340–355.
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. (2002a). Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol, 68, 5459–5463.
   PubMed Web of Science ®Google Scholar
• Ramage G, Tomsett K, Wickes BL, Lopez-Ribot JL, Redding SW. (2004). Denture stomatitis, a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 98, 53–59.
   PubMed Web of Science ®Google Scholar
• Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. (2001a). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother, 45, 2475–2479.
   PubMed Web of Science ®Google Scholar
• Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. (2002b). In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother, 46, 3634–3636.
   PubMed Web of Science ®Google Scholar
• Ramage G, Wickes BL, Lopez-Ribot JL. (2001b). Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab, 20, 42–44.
   PubMedGoogle Scholar
• Ramage G, Wickes BL, Lopez-Ribot JL. (2007). Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia, 164, 301–306.
   PubMed Web of Science ®Google Scholar
• Rasmussen TB, Givskov M. (2006). Quorum sensing inhibitors, a bargain of effects. Microbiology, 152, 895–904.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. (2007a). Oral and oesophageal squamous cell carcinoma–a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol, 43, 607–613.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Richardson M, Pfaller M, Koukila-Kahkola P, Perheentupa J, Saxen H. (2007b). Decreased susceptibility of Candida albicans to azole antifungals, a complication of long-term treatment in autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother, 60, 889–892.
   PubMedGoogle Scholar
• Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H. (2008). Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scand J Infect Dis, 40, 904–907.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Rusanen P, Richardson M, Meurman JH. (2006). Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbiol, 55, 1447–1451.
   PubMed Web of Science ®Google Scholar
• Richardson M, Jones B, Rautemaa R. (2007). Therapeutic Guidelines in Systemic Fungal Infections. London: Remedica Medical Publications.
   Google Scholar
• Richardson M, Warnock D. (2003). Fungal Infection; Diagnosis and Management. Oxford: Blackwell.
   Google Scholar
• Richardson R, Anttila V-J. (2010). Näin hoidan - Suun hiivainfektioiden diagnostiikka ja hoitoperiaatteet. Duodecim, 126, 174–180.
   Google Scholar
• Rusanen P, Siikala E, Uittamo J, Richardson M, Rautemaa R. (2009). A novel method for sampling the microbiota from the oral mucosa. Clin Oral Investig, 13, 243–246.
   Web of Science ®Google Scholar
• Salaspuro M. (2009). Acetaldehyde, a cumulative carcinogen in humans. Addiction, 104, 551–553.
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Jarvinen A. (2004). Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis, 38, 62–69.
   PubMed Web of Science ®Google Scholar
• Samaranayake LP, Keung Leung W, Jin L. (2009). Oral mucosal fungal infections. Periodontol 2000 49, 39–59.
   PubMed Web of Science ®Google Scholar
• Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. (1986). A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol, 15, 386–388.
   PubMedGoogle Scholar
• Scully C, Flint SR, Porter SR, Moos KF. (2004). Oral and maxillofacial diseases. London: Taylor & Francis.
   Google Scholar
• Shen S, Samaranayake LP, Yip HK. (2005). Coaggregation profiles of the microflora from root surface caries lesions. Arch Oral Biol, 50, 23–32.
   PubMed Web of Science ®Google Scholar
• Siikala E, Rautemaa R, Richardson M, Saxen H, Bowyer P, Sanglard D. (2010). Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother, 65, 2505–2513.
   PubMed Web of Science ®Google Scholar
• Sitheeque MA, Panagoda GJ, Yau J, Amarakoon AM, Udagama UR, Samaranayake LP. (2009). Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species. Chemotherapy, 55, 189–196.
   Google Scholar
• Sobel JD. (2010). Changing trends in the epidemiology of Candida blood stream infections, a matter for concern? Crit Care Med, 38, 990–992.
   Google Scholar
• Soysa NS, Samaranayake LP, Ellepola AN. (2008). Antimicrobials as a contributory factor in oral candidosis–a brief overview. Oral Dis, 14, 138–143.
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. (2001). Antibiotic resistance of bacteria in biofilms. Lancet, 358, 135–138.
   PubMed Web of Science ®Google Scholar
• Su CW, Gaskie S, Jamieson B, Triezenberg D. (2008). Clinical inquiries. What is the best treatment for oral thrush in healthy infants? J Fam Pract, 57, 484–485.
   PubMed Web of Science ®Google Scholar
• Thompson GR, 3rd Patel, PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J, Redding SW, Patterson TF. (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, 488–495.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Prigitano A, Biraghi E, Viviani MA. (2005). The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy, in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother, 56, 777–779.
   PubMed Web of Science ®Google Scholar
• Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. (2009). Chronic candidosis and oral cancer in APECED-patients, production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int J Cancer, 124, 754–756.
   PubMed Web of Science ®Google Scholar
• Vediyappan G, Rossignol T, d’Enfert C. (2010). Interaction of Candida albicans biofilms with antifungals, transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother, 54, 2096–2111.
   PubMed Web of Science ®Google Scholar
• Wilson M. (2005). Microbial inhabitants of humans, their ecology and role in health and disease. Cambridge: Cambridge University Press.
   Google Scholar